140 related articles for article (PubMed ID: 3954942)
1. Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
Allum WH; MacDonald F; Anderson P; Fielding JW
Br J Cancer; 1986 Feb; 53(2):203-10. PubMed ID: 3954942
[TBL] [Abstract][Full Text] [Related]
2. Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.
Dykes PW; Hine KR; Bradwell AR; Blackburn JC; Reeder TA; Drolc Z; Booth SN
Br Med J; 1980 Jan; 280(6209):220-2. PubMed ID: 7427084
[TBL] [Abstract][Full Text] [Related]
3. Polyclonal and monoclonal anti-CEA antibodies in immunolocalization of colorectal cancer.
Wahren B; Hammarström S; Harmenberg U; von Krusenstierna S; Larsson SA; Lundell G; Rudén U; Schnell PO
Tumour Biol; 1986; 7(5-6):361-9. PubMed ID: 3495029
[TBL] [Abstract][Full Text] [Related]
4. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.
Berche C; Mach JP; Lumbroso JD; Langlais C; Aubry F; Buchegger F; Carrel S; Rougier P; Parmentier C; Tubiana M
Br Med J (Clin Res Ed); 1982 Nov; 285(6353):1447-51. PubMed ID: 6814596
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of carcinoembryonic antigen (CEA) monoclonal antibodies (McAbs)].
Cheng M; Yin HZ; Feng XQ
Zhonghua Zhong Liu Za Zhi; 1987 Jan; 9(1):14-6. PubMed ID: 3297586
[TBL] [Abstract][Full Text] [Related]
7. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immunolocalization in gastrointestinal cancer.
Allum WH; MacDonald F; Fielding JW
NCI Monogr; 1987; (3):11-7. PubMed ID: 3821910
[TBL] [Abstract][Full Text] [Related]
9. [Experiences with determining carcinoembryonic antigen in tumors of the digestive tract].
Pelikán A
Zentralbl Chir; 1986; 111(18):1113-8. PubMed ID: 3024422
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen (CEA): comparison of the Farr and solid-phase methods for detection of CEA.
McPherson TA; Band PR; Grace M; Hyde HA; Patwardhan VC
Int J Cancer; 1973 Jul; 12(1):42-54. PubMed ID: 4597862
[No Abstract] [Full Text] [Related]
11. Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography.
Kmiot WA; Stonelake P; Sagar G; Donovan IA; Neoptolemos JP; Notghi A; Harding LK
Nucl Med Commun; 1993 Sep; 14(9):788-91. PubMed ID: 8233244
[TBL] [Abstract][Full Text] [Related]
12. In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcinoembryonic antigen.
Armitage NC; Perkins AC; Durrant LG; Ellis IO; Ballantyne KC; Harrison RC; Riley AM; Robins RA; Wastie ML; Hardcastle JD
Br J Surg; 1986 Dec; 73(12):965-9. PubMed ID: 3790959
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.
Boxer GM; Begent RH; Kelly AM; Southall PJ; Blair SB; Theodorou NA; Dawson PM; Ledermann JA
Br J Cancer; 1992 Jun; 65(6):825-31. PubMed ID: 1616854
[TBL] [Abstract][Full Text] [Related]
14. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
Heptner G; Domschke S; Domschke W
Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
[No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer.
Fujimoto S; Kitsukawa U; Itoh K
Ann Surg; 1979 Jan; 189(1):34-8. PubMed ID: 758861
[TBL] [Abstract][Full Text] [Related]
16. [99mTc anti-carcinoembryonic antigen in colorectal cancer].
Frederiksen PB; Rasmussen JW; Lassen E; Fenger C; Kronborg O; Ditzel H
Ugeskr Laeger; 1994 Mar; 156(11):1641-5. PubMed ID: 8009660
[TBL] [Abstract][Full Text] [Related]
17. [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma].
Ohashi A
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):297-306. PubMed ID: 3713682
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of the plasma-CEA-concentrations in the primary diagnosis of malignoma of the digestive tract].
Aver IO; Münch L; Epping J; Schmid L
Z Gastroenterol Verh; 1976; (11):73-7. PubMed ID: 65868
[No Abstract] [Full Text] [Related]
19. Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.
Begent RH; Ledermann JA; Green AJ; Bagshawe KD; Riggs SJ; Searle F; Keep PA; Adam T; Dale RG; Glaser MG
Br J Cancer; 1989 Sep; 60(3):406-12. PubMed ID: 2789951
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
